Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium

Clinical and Vaccine Immunology

Volumn 18, Issue 11, 2011, Pages 1823-1833

  Ferreira, P C D ^a,b   Da Silva, J B ^a,b   Piazza, R M F ^a   Eckmann, L ^c   Ho, P L ^a,b   Oliveira, M L S ^a,b  

^a INSTITUTO BUTANTAN   (Brazil)

^b Instituto de Pesquisas Tecnologicas   (Brazil)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTIMIN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; INTIMIN; LACTOBACILLUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CELLULAR IMMUNITY; CITROBACTER RODENTIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; INTESTINE FLORA; LACTOBACILLUS CASEI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CITROBACTER RODENTIUM; COLON; DRUG CARRIERS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GENETIC VECTORS; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-6; LACTOBACILLUS CASEI; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; SPLEEN; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC;

EID: 80455179691     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05262-11     Document Type: Article

References (71)

1. Abe, C. M., et al. 2009. Virulence features of atypical enteropathogenic Escherichia coli identified by the eae(+) EAF-negative stx(-) genetic profile. Diagn. Microbiol. Infect. Dis. 64:357-365.
2. Adachi, K., et al. 2010. Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7. Vaccine 28:2810-2817.
3. Adu-Bobie, J., L. R. Trabulsi, M. M. Carneiro-Sampaio, G. Dougan, and G. Frankel. 1998. Identification of immunodominant regions within the C-terminal cell binding domain of intimin alpha and intimin beta from enteropathogenic Escherichia coli. Infect. Immun. 66:5643-5649. (Pubitemid 28531817)
4. Agin, T. S., et al. 2005. Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin. Infect. Immun. 73:6608-6619. (Pubitemid 41368827)
5. Aida, Y., and M. J. Pabst. 1990. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 132:191-195. (Pubitemid 20281877)
6. Aidar-Ugrinovich, L., et al. 2007. Serotypes, virulence genes, and intimin types of Shiga toxin-producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC) isolated from calves in Sao Paulo, Brazil. Int. J. Food Microbiol. 115:297-306. (Pubitemid 46400879)
7. Alrifai, S. B., A. Alsaadi, Y. A. Mahmood, A. A. Ali, and L. A. Al-Kaisi. 2009. Prevalence and etiology of nosocomial diarrhoea in children < 5 years in Tikrit teaching hospital. East Mediterr. Health J. 15:1111-1118.
8. Batchelor, M., et al. 2000. Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli. EMBO J. 19:2452-2464. (Pubitemid 30323535)
9. Belyakov, I. M., and J. D. Ahlers. 2009. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J. Immunol. 183:6883-6892.
10. BenMohamed, L., et al. 2002. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur. J. Immunol. 32:2274-2281. (Pubitemid 34965890)
11. Bermúdez-Humarán, L. G., et al. 2005. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 175:7297-7302. (Pubitemid 41713425)
12. Black, R. E., et al. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969-1987.
13. Bry, L., M. Brigl, and M. B. Brenner. 2006. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect. Immun. 74:673-681. (Pubitemid 43023123)
14. Cai, K., et al. 2010. Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response. Can. J. Microbiol. 56:389-398.
15. Camara, L. M., S. B. Carbonare, M. L. Silva, and M. M. Carneiro-Sampaio. 1994. Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins. Int. Arch. Allergy Immunol. 103:307-310.
16. Campos, I. B., et al. 2008. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect. 10:481-488.
17. Carbonare, S. B., M. L. Silva, P. Palmeira, and M. M. Carneiro-Sampaio. 1997. Human colostrum IgA antibodies reacting to enteropathogenic Escherichia coli antigens and their persistence in the faeces of a breastfed infant. J. Diarrhoeal Dis. Res. 15:53-58. (Pubitemid 127758711)
18. Clarke, S. C., R. D. Haigh, P. P. Freestone, and P. H. Williams. 2003. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin. Microbiol. Rev. 16:365-378. (Pubitemid 36871312)
19. Cravioto, A., et al. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1247-1255.
20. Cuburu, N., et al. 2007. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25:8598-8610. (Pubitemid 350192038)
21. Dann, S. M., et al. 2008. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J. Immunol. 180:6816-6826.
22. de Lucia Hernani, M., et al. 2011. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice. FEMS Immunol. Med. Microbiol. 62:263-272.
23. Estrada-Garcia, T., et al. 2009. Association of diarrheagenic Escherichia coli pathotypes with infection and diarrhea among Mexican children and association of atypical enteropathogenic E. coli with acute diarrhea. J. Clin. Microbiol. 47:93-98.
24. Ferreira, D. M., et al. 2009. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16:636-645.
25. Ferreira, P. C., et al. 2008. Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells. FEMS Immunol. Med. Microbiol. 54:245-254.
26. Fitzhenry, R. J., et al. 2002. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7. Gut 50:180-185. (Pubitemid 34087928)
27. Frankel, G., and A. D. Phillips. 2008. Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol. 10:549-556. (Pubitemid 351194084)
28. Frankel, G., et al. 1996. Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect. Immun. 64:5315-5325. (Pubitemid 26403998)
29. Franzolin, M. R., et al. 2005. Prevalence of diarrheagenic Escherichia coli in children with diarrhea in Salvador, Bahia, Brazil. Mem. Inst. Oswaldo Cruz 100:359-363. (Pubitemid 41190686)
30. Ghaem-Maghami, M., et al. 2001. Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect. Immun. 69:5597-5605. (Pubitemid 32786496)
31. Ghosh, P. K., and A. Ali. 2010. Isolation of atypical enteropathogenic Escherichia coli from children with and without diarrhoea in Delhi and the National Capital Region, India. J. Med. Microbiol. 59:1156-1162.
32. Grangette, C., et al. 2002. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 20:3304-3309. (Pubitemid 35245814)
33. Hanniffy, S. B., A. T. Carter, E. Hitchin, and J. M. Wells. 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195:185-193. (Pubitemid 46080050)
34. Higgins, L. M., G. Frankel, G. Douce, G. Dougan, and T. T. MacDonald. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67:3031-3039. (Pubitemid 29244725)
35. Ito, K., et al. 2007. Intimin types determined by heteroduplex mobility assay of intimin gene (eae)-positive Escherichia coli strains. J. Clin. Microbiol. 45:1038-1041. (Pubitemid 46427733)
36. Judge, N. A., H. S. Mason, and A. D. O'Brien. 2004. Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect. Immun. 72:168-175. (Pubitemid 38018174)
37. Kane, A., J. Lloyd, M. Zaffran, L. Simonsen, and M. Kane. 1999. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull. World Health Organ. 77:801-807.
38. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140. (Pubitemid 39490066)
39. Keller, R., T. D. Hilton, H. Rios, E. C. Boedeker, and J. B. Kaper. 2010. Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. Microb. Pathog. 48:1-8.
40. Khare, S., et al. 2010. Vaccination with attenuated Salmonella enterica Dublin expressing E coli O157:H7 outer membrane protein Intimin induces transient reduction of fecal shedding of E coli O157:H7 in cattle. BMC Vet. Res. 6:35.
41. Koga, P. C. M., et al. 2003. Polyclonal anti-intimin antibody: immunological characterization and its use in EPEC diagnosis. Braz. J. Microbiol. 34:5-7.
42. Lee, J. S., et al. 2006. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J. Virol. 80:4079-4087.
43. Maaser, C., et al. 2004. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72:3315-3324. (Pubitemid 38697754)
44. Marcucci, F., et al. 2009. The future of sublingual immunotherapy. Int. J. Immunopathol. Pharmacol. 22:31-33.
45. Medina, M., et al. 2008. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect. Immun. 76:2696-2705.
46. Menezes, M. A., et al. 2010. Identification of enteropathogenic and enterohaemorrhagic Escherichia coli strains by immunoserological detection of intimin. J. Appl. Microbiol. 108:878-887.
47. Mestecky, J., M. W. Russell, and C. O. Elson. 2007. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J. Immunol. 179:5633-5638.
48. Miyake, M., et al. 2005. Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli. Biochem. Biophys. Res. Commun. 337:922-927. (Pubitemid 41447002)
49. Mora, A., et al. 2009. HeLa-cell adherence patterns and actin aggregation of enteropathogenic Escherichia coli (EPEC) and Shiga-toxin-producing E. coli (STEC) strains carrying different eae and tir alleles. Int. Microbiol. 12:243-251.
50. Nara, J. M., et al. 2010. Differentiation of typical and atypical enteropathogenic Escherichia coli using colony immunoblot for detection of bundleforming pilus expression. J. Appl. Microbiol. 109:35-43.
51. Nascimento, I. P., et al. 2000. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68:4877-4883.
52. Nguyen, R. N., L. S. Taylor, M. Tauschek, and R. M. Robins-Browne. 2006. Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg. Infect. Dis. 12:597-603.
53. Novak, N., J. Haberstok, T. Bieber, and J. P. Allam. 2008. The immune privilege of the oral mucosa. Trends Mol. Med. 14:191-198.
54. Oliveira, M. L., et al. 2006. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect. 8:1016-1024.
55. Oliveira, M. L., A. P. Areas, and P. L. Ho. 2007. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Expert Rev. Vaccines 6:419-429. (Pubitemid 46911604)
56. Oswald, E., et al. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64-71. (Pubitemid 30016678)
57. Palmeira, P., L. Yu Ito, C. Arslanian, and M. M. Carneiro-Sampaio. 2007. Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn. Eur. J. Pediatr. 166:413-419. (Pubitemid 46450473)
58. Parissi-Crivelli, A., J. M. Parissi-Crivelli, and J. A. Giron. 2000. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. J. Clin. Microbiol. 38:2696-2700. (Pubitemid 30485152)
59. Pérez, C., O. G. Gomez-Duarte, and M. L. Arias. 2010. Diarrheagenic Escherichia coli in children from Costa Rica. Am. J. Trop. Med. Hyg. 83:292-297.
60. Ramachandran, V., et al. 2003. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J. Clin. Microbiol. 41:5022-5032. (Pubitemid 37429912)
61. Reveneau, N., M. C. Geoffroy, C. Locht, P. Chagnaud, and A. Mercenier. 2002. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20:1769-1777. (Pubitemid 34242832)
62. Robins-Browne, R. M., et al. 2004. Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia. Emerg. Infect. Dis. 10:1797-1805. (Pubitemid 39328251)
63. Savkovic, S. D., A. Koutsouris, and G. Hecht. 1997. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol. 273:C1160-C1167.
64. Vallance, B. A., W. Deng, K. Jacobson, and B. B. Finlay. 2003. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71:3443-3453. (Pubitemid 36637573)
65. Van Overtvelt, L., et al. 2008. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int. Arch. Allergy Immunol. 145:152-162.
66. Van Overtvelt, L., et al. 2010. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 28:2986-2992.
67. Wells, J. M., and A. Mercenier. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6:349-362. (Pubitemid 351552656)
68. Wiles, S., et al. 2004. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol. 6:963-972. (Pubitemid 39255609)
69. Wiles, S., K. M. Pickard, K. Peng, T. T. MacDonald, and G. Frankel. 2006. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect. Immun. 74:5391-5396. (Pubitemid 44300459)
70. Zapata-Quintanilla, L. B., et al. 2009. Seric and secretory antibodies reactive to alpha, beta and gamma intimins of Escherichia coli in healthy Brazilian adults. FEMS Immunol. Med. Microbiol. 57:32-39.
71. Zhang, H., J. Zhang, and J. B. Streisand. 2002. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 41:661-680.